Trend
DailyUptrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minNo data
Daily trend turns down below $40.50
Key levels
Resistance$42.81
Resistance$40.50
Support$39.00
Support$38.05
Latest news & SEC filings
No headlines in the last 90 days.
· Healthcare
SEPT Low Target
$33.15
SEPT Mid Target
$39.00
SEPT High Target
$44.85
Analyst Consensus
$39.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for XOMA.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$36.02
49
Moat Score
NARROW
5/9
Piotroski Score
-2.7
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| WYSZOMIERSKI JACK L | director | Buy | 3,586 | - | May 21, 2026 |
| LIMBER JOSEPH M | director | Buy | 3,586 | - | May 21, 2026 |
| Hernday Natasha | director | Buy | 3,586 | - | May 21, 2026 |
| PERRY MATTHEW D | director | Buy | 3,586 | - | May 21, 2026 |
| Franklin Heather L | director | Buy | 3,586 | - | May 21, 2026 |
| Kosacz Barbara | director | Buy | 3,586 | - | May 21, 2026 |
| BVF PARTNERS L P/IL | 10% owner | Buy | 2,313,000 | $9.3M | May 14, 2026 |
| BVF PARTNERS L P/IL | 10% owner | Buy | 1,506,000 | $6.1M | May 14, 2026 |
| BVF PARTNERS L P/IL | 10% owner | Buy | 412,000 | $1.7M | May 14, 2026 |
| BVF PARTNERS L P/IL | 10% owner | Buy | 772,000 | $3.1M | May 14, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
83.1%
3yr Revenue CAGR
N/A%
EPS Growth YoY
188.48%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
SEPT's Trading AI has generated a free, downloadable PDF research report for XOMA Royalty Corp (XOMA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →XOMA Royalty Corp (XOMA) is at $40.17, down 9.16% (-$4.05) at the Jul 13, 2026 close.
The average analyst price target for XOMA is $39.00, ranging from $39 to $39, based on 1 analysts. Latest: HC Wainwright & Co. downgrade on Apr 30, 2026.
Analyst ratings for XOMA: 0 Buy, 0 Hold, 1 Sell — consensus Sell.
XOMA last reported on Mar 18, 2026: EPS $0.12 vs -$0.13 expected — a beat of 192.3%.
XOMA trades at a P/E of 30.7.
Yes. XOMA's dividend yield is 1.14%.
Support: $39.00, $38.05, $37.00. Resistance: $40.50, $42.81, $43.99.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.